Evaluation of anxiety sensitivity in patients with psoriasis

Background/Objectives: Psoriasis is an inflammatory skin disease characterized by erythematous squamous plaques. It has negative physical, psychological, and social effects. Psychiatric comorbidities such as anxiety and depression can accompany to psoriasis. In our study, we aimed to evaluate the an...

Full description

Saved in:
Bibliographic Details
Main Authors: Hilal Kaya Erdogan (Author), Ali Ercan Altinoz (Author), Ersoy Acer (Author), Zeynep Nurhan Saracoglu (Author), Muzaffer Bilgin (Author)
Format: Book
Published: Wolters Kluwer Medknow Publications, 2019-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a6a564a8cf9a48faa5fefd3db566e67d
042 |a dc 
100 1 0 |a Hilal Kaya Erdogan  |e author 
700 1 0 |a Ali Ercan Altinoz  |e author 
700 1 0 |a Ersoy Acer  |e author 
700 1 0 |a Zeynep Nurhan Saracoglu  |e author 
700 1 0 |a Muzaffer Bilgin  |e author 
245 0 0 |a Evaluation of anxiety sensitivity in patients with psoriasis 
260 |b Wolters Kluwer Medknow Publications,   |c 2019-01-01T00:00:00Z. 
500 |a 1027-8117 
500 |a 2223-330X 
500 |a 10.4103/ds.ds_5_18 
520 |a Background/Objectives: Psoriasis is an inflammatory skin disease characterized by erythematous squamous plaques. It has negative physical, psychological, and social effects. Psychiatric comorbidities such as anxiety and depression can accompany to psoriasis. In our study, we aimed to evaluate the anxiety sensitivity (AS) in psoriasis patients. Methods: We included 89 psoriasis patients, 44 controls with nonpsychodermatological disease and 59 healthy volunteers to study. Dermatological examinations were performed, and the Psoriasis Area and Severity Index (PASI) values were calculated. Participants completed a sociodemographic information form, Beck Anxiety Inventory and AS Index-3. Results: Both the psoriasis group and the control group with nonpsychodermatological disease had higher anxiety scores than the healthy control group. Psoriasis patients were found to have higher AS scores than both control group with nonpsychodermatological disease and healthy controls. When the psoriasis group was divided into two groups according to the presence of systemic disease or psoriatic arthritis; there was no difference between the groups in terms of psychometric measurements. Furthermore, there was no significant correlation between PASI scores and disease duration and psychometric evaluations. Conclusion: Our study is the first to show that the AS of psoriasis patients is significantly higher than healthy controls and of those with nonpsychodermatological diseases. It is not clear that high AS in these patients is a predisposing factor to the disease or a consequence of the disease. 
546 |a EN 
690 |a Anxiety 
690 |a anxiety sensitivity 
690 |a psoriasis 
690 |a Dermatology 
690 |a RL1-803 
655 7 |a article  |2 local 
786 0 |n Dermatologica Sinica, Vol 37, Iss 1, Pp 28-32 (2019) 
787 0 |n http://www.dermsinica.org/article.asp?issn=1027-8117;year=2019;volume=37;issue=1;spage=28;epage=32;aulast=Erdogan 
787 0 |n https://doaj.org/toc/1027-8117 
787 0 |n https://doaj.org/toc/2223-330X 
856 4 1 |u https://doaj.org/article/a6a564a8cf9a48faa5fefd3db566e67d  |z Connect to this object online.